Halozyme Therapeutics, Inc. (HALO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:00AM EDT. Market open.
| Previous close | 49.66 |
| Open | 49.74 |
| Bid | 49.00 x 100 |
| Ask | 49.45 x 200 |
| Day's range | 49.09 - 49.99 |
| 52-week range | 32.83 - 53.00 |
| Volume | |
| Avg. volume | 1,059,896 |
| Market cap | 6.271B |
| Beta (5Y monthly) | 1.28 |
| PE ratio (TTM) | 20.44 |
| EPS (TTM) | 2.41 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 56.78 |
ZacksHere's Why Halozyme Therapeutics (HALO) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ZacksWhy Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?
Kodiak Sciences (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GuruFocus.comInsider Sale: Director Matthew Posard Sells Shares of Halozyme Therapeutics Inc (HALO)
Director Matthew Posard sold 20,000 shares of Halozyme Therapeutics Inc (NASDAQ:HALO) on June 12, 2024, as reported in a recent SEC Filing.
© 2024 Yahoo. All rights reserved.